Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia.

Large granular lymphocytic (LGL) leukemia is characterized by clonal expansion of cytotoxic T cells or natural killer cells. Recently, somatic mutations in the signal transducer and activator of transcription 3 (STAT3) gene were discovered in 28% to 40% of LGL leukemia patients. By exome and transcriptome sequencing of 2 STAT3 mutation-negative LGL leukemia patients, we identified a recurrent, somatic missense mutation (Y665F) in the Src-like homology 2 domain of the STAT5b gene. Targeted amplicon sequencing of 211 LGL leukemia patients revealed 2 additional patients with STAT5b mutations (N642H), resulting in a total frequency of 2% (4 of 211) of STAT5b mutations across all patients. The Y665F and N642H mutant constructs increased the transcriptional activity of STAT5 and tyrosine (Y694) phosphorylation, which was also observed in patient samples. The clinical course of the disease in patients with the N642H mutation was aggressive and fatal, clearly different from typical LGL leukemia with a relatively favorable outcome. This is the first time somatic STAT5 mutations are discovered in human cancer and further emphasizes the role of STAT family genes in the pathogenesis of LGL leukemia.

[1]  Keunsoo Kang,et al.  Comprehensive meta-analysis of Signal Transducers and Activators of Transcription (STAT) genomic binding patterns discerns cell-specific cis-regulatory modules , 2012, BMC Genomics.

[2]  Laura A. Sullivan,et al.  Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylation. , 2012, Cancer cell.

[3]  S. Mustjoki,et al.  STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia. , 2012, Blood.

[4]  T. Loughran,et al.  Large granular lymphocyte leukemia: from dysregulated pathways to therapeutic targets. , 2012, Future oncology.

[5]  Kari Christine Nadeau,et al.  The STAT5b Pathway Defect and Autoimmunity , 2012, Front. Immun..

[6]  S. Mustjoki,et al.  Somatic STAT3 mutations in large granular lymphocytic leukemia. , 2012, The New England journal of medicine.

[7]  Mikko Koski,et al.  Chipster: user-friendly analysis software for microarray and other high-throughput data , 2011, BMC Genomics.

[8]  B. Ebert,et al.  The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors. , 2011, Blood.

[9]  S. Mustjoki,et al.  Mono/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy. , 2010, Blood.

[10]  Liisa Holm,et al.  Advances and pitfalls of protein structural alignment. , 2009, Current opinion in structural biology.

[11]  S. Mustjoki,et al.  Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy , 2008, Leukemia.

[12]  Torsten Schwede,et al.  The SWISS-MODEL Repository and associated resources , 2008, Nucleic Acids Res..

[13]  R. Albert,et al.  Network model of survival signaling in large granular lymphocyte leukemia , 2008, Proceedings of the National Academy of Sciences.

[14]  Gordon K. Smyth,et al.  A comparison of background correction methods for two-colour microarrays , 2007, Bioinform..

[15]  B. Little,et al.  Growth Hormone Insensitivity and Severe Short Stature in Siblings: A Novel Mutation at the Exon 13-Intron 13 Junction of the STAT5b Gene , 2007, Hormone Research in Paediatrics.

[16]  E. Burks,et al.  Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndrome. , 2006, Blood reviews.

[17]  L. Hennighausen,et al.  Stat5a/b are essential for normal lymphoid development and differentiation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Mario Cazzola,et al.  A gain-of-function mutation of JAK2 in myeloproliferative disorders. , 2005, The New England journal of medicine.

[19]  Gordon K Smyth,et al.  Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .

[20]  Terry Speed,et al.  Normalization of cDNA microarray data. , 2003, Methods.

[21]  M. D'urso,et al.  The structure of human STAT5A and B genes reveals two regions of nearly identical sequence and an alternative tissue specific STAT5B promoter. , 2002, Gene.

[22]  J. Turkson,et al.  Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. , 2001, The Journal of clinical investigation.

[23]  A. Miyajima,et al.  Constitutive Activation of STAT5 by a Point Mutation in the SH2 Domain* , 2000, The Journal of Biological Chemistry.

[24]  S. Asano,et al.  Constitutively active STAT5A and STAT5B in vitro and in vivo: mutation of STAT5 is not a frequent cause of leukemogenesis. , 2000, International journal of hematology.

[25]  Bernd Groner,et al.  TRANSCRIPTION FACTOR STAT3B/DNA COMPLEX , 1999 .

[26]  T. Loughran,et al.  Large granular lymphocyte leukemia , 2007, Current hematologic malignancy reports.

[27]  W. Leonard,et al.  Stat5b Is Essential for Natural Killer Cell–mediated Proliferation and Cytolytic Activity , 1998, The Journal of experimental medicine.

[28]  S. Becker,et al.  Three-dimensional structure of the Stat3β homodimer bound to DNA , 1998, Nature.

[29]  W. Leonard,et al.  Jaks and STATs: biological implications. , 1998, Annual review of immunology.

[30]  R. Snell,et al.  Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[31]  L. Hennighausen,et al.  Stat5a is mandatory for adult mammary gland development and lactogenesis. , 1997, Genes & development.

[32]  J. Griffin,et al.  Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl , 1996, The Journal of experimental medicine.

[33]  A. Miyajima,et al.  Interleukin‐3, granulocyte‐macrophage colony‐stimulating factor, and interleukin‐5 transduce signals through two forms of STAT5 , 1995, Journal of leukocyte biology.

[34]  A. Miyajima,et al.  Interleukin‐3, granulocyte‐macrophage colony stimulating factor and interleukin‐5 transduce signals through two STAT5 homologs. , 1995, The EMBO journal.

[35]  B. Groner,et al.  Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. , 1994, The EMBO journal.

[36]  T. Loughran,et al.  Clonal diseases of large granular lymphocytes. , 1993, Blood.

[37]  C. Disteche,et al.  Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia. , 1985, Annals of internal medicine.